Tandem Diabetes Care

Update in progress

TNDM (NasdaqGM)

Company RatingNeutral
SectorHealthcare
IndustryMedical Devices

Tandem Diabetes Care, Inc. designs, develops, and markets insulin delivery solutions for people with diabetes in the U.S. and worldwide. Its offerings include the t:slim X2 insulin delivery system and the Tandem Mobi automated insulin delivery pump, plus single-use cartridges and infusion sets. It also provides the Tandem Device Updater, Tandem Source data platform, and the Sugarmate mobile app. The company collaborates with the University of Virginia Center for Diabetes Technology on automated closed-loop systems. Formerly Phluid Inc., it renamed in 2008. Founded in 2006 and based in San Diego.

Company score

Sentiment: -0.53; SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
Environment: -0.02; EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
Social: -0.77; SocialAssesses the company’s influence on employees, customers, communities, and wider society.−10 negative · 0 neutral · +10 positive
Governance: -0.47; GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
Sustainability: -0.34; SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
Impact Score: -0.43; Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive